We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+13.5%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$104B
AUM Growth
+$5.37B
Cap. Flow
-$4.4B
Cap. Flow %
-4.24%
Top 10 Hldgs %
23.25%
Holding
3,207
New
74
Increased
1,562
Reduced
1,216
Closed
156

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$249M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$127M
3
AVGO icon
Broadcom
AVGO
+$60.3M
4
UBS icon
UBS Group
UBS
+$56.9M
5
CB icon
Chubb
CB
+$50.9M

Sector Composition

Rank Sector Weight
1 Technology 26.77%
2 Financials 15.13%
3 Healthcare 14.14%
4 Consumer Discretionary 10.14%
5 Industrials 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIG icon
276
American International
AIG
$41.8B
$73.6M 0.07%
1,086,973
-11,685
-1% -$745K
MO icon
277
Altria Group
MO
$114B
$73.6M 0.07%
1,825,257
+27,557
+2% +$1.14M
NTAP icon
278
NetApp
NTAP
$35.9B
$73.6M 0.07%
834,375
+17,294
+2% +$1.39M
MAR icon
279
Marriott International
MAR
$91.5B
$73.5M 0.07%
326,116
+6,971
+2% +$1.41M
KEYS icon
280
Keysight
KEYS
$55B
$73.5M 0.07%
461,982
-30,154
-6% -$4.1M
GLW icon
281
Corning
GLW
$126B
$73.5M 0.07%
2,412,801
+79,579
+3% +$2.28M
EXAS
282
DELISTED
Exact Sciences
EXAS
$73.2M 0.07%
989,644
+2,067
+0.2% +$135K
IT icon
283
Gartner
IT
$10.1B
$72.8M 0.07%
161,442
+261
+0.2% +$104K
OKTA icon
284
Okta
OKTA
$24.6B
$72.6M 0.07%
801,791
-6,850
-0.8% -$523K
INSP icon
285
Inspire Medical Systems
INSP
$1.5B
$72.4M 0.07%
356,059
+7,759
+2% +$1.26M
NUE icon
286
Nucor
NUE
$59.5B
$71.6M 0.07%
411,318
-37,530
-8% -$5.95M
LYB icon
287
LyondellBasell Industries
LYB
$19.6B
$71.3M 0.07%
749,821
-41
-0% -$3.83K
IQV icon
288
IQVIA
IQV
$38.4B
$71M 0.07%
306,753
-22,940
-7% -$4.71M
JCI icon
289
Johnson Controls International
JCI
$88.7B
$71M 0.07%
1,231,209
+39,608
+3% +$2.08M
EXC icon
290
Exelon
EXC
$47B
$70.3M 0.07%
1,956,898
+104,401
+6% +$4.02M
TXG icon
291
10x Genomics
TXG
$5.97B
$70M 0.07%
1,250,102
-87,334
-7% -$3.8M
CM icon
292
Canadian Imperial Bank of Commerce
CM
$109B
$69.7M 0.07%
1,447,441
-175,100
-11% -$7M
AME icon
293
Ametek
AME
$55.9B
$69M 0.07%
418,469
-13,182
-3% -$2.01M
DHI icon
294
D.R. Horton
DHI
$41B
$68.9M 0.07%
453,595
-7,462
-2% -$919K
ODFL icon
295
Old Dominion Freight Line
ODFL
$44B
$68.3M 0.07%
337,002
-10,462
-3% -$2.08M
FIS icon
296
Fidelity National Information Services
FIS
$23.1B
$67.9M 0.07%
1,130,767
-39,074
-3% -$2.14M
TMDX icon
297
Transmedics
TMDX
$2.82B
$67.8M 0.07%
859,478
-272,425
-24% -$16.4M
TDG icon
298
TransDigm Group
TDG
$71.9B
$67.8M 0.07%
67,046
+83
+0.1% +$76.6K
B
299
Barrick Mining
B
$62.6B
$67.5M 0.07%
3,733,219
-155,963
-4% -$2.56M
EOG icon
300
EOG Resources
EOG
$77.6B
$66.9M 0.06%
553,184
-38,018
-6% -$4.73M

Similar funds

Credit Suisse's Q4 2023 Portfolio in Review

As of Q4 2023, Credit Suisse held 3,207 positions worth $104B, up 5.5% from $98.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Credit Suisse withdrew a net $4.4B in Q4 2023, closing 156 positions and reducing 1,216 holdings. Its most notable exit was Sprott Uranium Miners ETF, an estimated $305M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Credit Suisse opened a new position in Veralto worth $31.3M.

  • Credit Suisse's largest Q4 2023 buy was Veralto: 380,178 shares worth $31.3M.
  • Credit Suisse added most to iShares Russell 2000 ETF in Q4 2023, an estimated $249M increase.
  • Credit Suisse's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $210M.
  • Credit Suisse fully exited Sprott Uranium Miners ETF in Q4 2023, selling an estimated $305M.
  • Credit Suisse's ten largest holdings make up 23% of its $104B portfolio in Q4 2023.
  • Credit Suisse opened 74 new positions and closed 156 in Q4 2023.
  • Credit Suisse's portfolio value rose 5.5% quarter-over-quarter to $104B.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.